Navigation Links
Phase III pivotal results presented of VYVANSE to treat ADHD in adults
Date:5/8/2008

was approximately 60 percent across all doses and was significantly greater than placebo.

The most commonly reported adverse events in this study were generally mild to moderate in severity and included decreased appetite, insomnia and dry mouth.

On April 23, 2008, Shire received approval from the U.S. Food and Drug Administration (FDA) for VYVANSE for the treatment of ADHD in adults aged 18 to 55 years. The FDA approved VYVANSE for the treatment of ADHD in children aged 6 to 12 years on February 23, 2007.


'/>"/>

Contact: Lucia Lodato
lucia.lodato@porternovelli.com
917-617-3058
Porter Novelli
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
2. NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program
3. Phase 3 data Re: Anti-RSV antibody to be presented at Pediatric Academic Societies Annual Meeting
4. Wal-Mart Launches Phase Three of $4 Prescription Program
5. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
6. Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
7. Arpida Provides Comprhensive Overview of Pivotal Phase III Trial Data
8. QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension
9. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
10. Many Phase 3 Cancer Drug Trials Yield Effective Medicines
11. Cancer treatments in phase 3 trials successful up to half of the time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- Both drinking ... risk factors for alcohol abuse by high school students, ... a survey of high school students who drink, could ... those who already drink, to stop them from becoming ... distinguish between age of first alcohol use and progression ...
(Date:9/23/2014)... Grinnell Mutual seeks submissions from ... the Midwest. Working Together Making It Better will ... with projects positively impacting their communities. , “So ... their communities a better places,” said Grinnell ... Barb Baker. “Their leadership—as coaches, as volunteers, as ...
(Date:9/23/2014)... CORVALLIS, Ore. A recent Oregon survey about an ... into the daily routine of elementary school students found ... students and teachers, and offered clear advantages for overly ... was developed and produced by the Healthy Youth Program ... and is available nationally. , Brain Breaks leads children ...
(Date:9/23/2014)... BC (PRWEB) September 23, 2014 Vancouver ... will now be offering commercial electrical services in Vancouver, ... of operations; whether it is a small maintenance project ... personalize its solution package to meet the needs of ... that the services will be of an affordable price. ...
(Date:9/23/2014)... 2014 SOURCE: Solutions from Our ... were made to Rimidi Diabetes and ... with business solutions to challenges faced by patients and ... collaboration between The Hitachi Foundation, Village ... entrepreneurs with the investment capital, mentoring, and support needed ...
Breaking Medicine News(10 mins):Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Pro Ace Now Offers Commercial Electrical Services in Vancouver 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5
... Research &,Design Journal (HERD) is an interdisciplinary, peer-reviewed, ... and practice of,evidence-based healthcare design by disseminating research ... practice. The,vision of HERD is to improve healthcare ... those receiving and giving care., HERD is ...
... IL, April 10, 2008 The American Pain Society (APS), ... second annual Clinical Centers of Excellence in Pain Management ... Six multidisciplinary pain programs were recognized. They are: ... Pain Management Center, Lebanon, NH , ...
... Spanish . , The removal through endoscopy of ... oesophagus can avoid complete extirpation of this part of ... University Hospital of Navarra for the last three years, ... Endoscopy in the Digestive System, organized by the Digestive ...
... then a research team from the University of Reading and ... may have good news for you. , They have found ... age-related deficits in memory, according to a study soon to ... Medicine. The researchers working at the Schools of Food ...
... 10 - Entries for the eighth,annual Michael E. ... Research (FBR) and named after FBR,s chairman, are ... all professional journalists whose reporting,has enhanced public understanding ... humane and responsible use of animal models., ...
... ... Network, STAMFORD, Conn., April ... lower middle-market special situation,and deep value investments, announced today that it has ... with a commitment from funds managed by the investment management,arm of a ...
Cached Medicine News:Health News:The Center for Health Design & Vendome Group Unveil Premiere Issue of Health Environments Research & Design Journal (HERD) - http://www.herdjournal.com 2Health News:American Pain Society announces recipients of Clinical Centers of Excellence Awards 2Health News:American Pain Society announces recipients of Clinical Centers of Excellence Awards 3Health News:Removal of superficial tumors in esophagus by endoscopy can avoid extirpation of this part 2Health News:Removal of superficial tumors in esophagus by endoscopy can avoid extirpation of this part 3Health News:Removal of superficial tumors in esophagus by endoscopy can avoid extirpation of this part 4Health News:Getting forgetful? Then blueberries may hold the key 2Health News:DeBakey Awards to Recognize Excellence in Biomedical Research Journalism 2Health News:Atlantic Street Capital Announces First Close 2
(Date:9/23/2014)... , September 23, 2014 ... has announced the addition of the  "Large ... to their offering.  ,     ... drug delivery market holds significant potential for ... vials and painful needles to the modern-day ...
(Date:9/23/2014)... , Sept. 23, 2014  MEDIMETRIKS PHARMACEUTICALS ... William Resnick have been elected to ... Mr. Lary, who will serve on ... and investment experience to the Company.  Mr. Lary ... Advisors, LLC, a leading institutional investment firm.  Mr. ...
(Date:9/23/2014)... 2014  KemPharm, Inc., a clinical-stage specialty pharmaceutical ... proprietary new molecular entity (NME) prodrugs, announced today ... from Health Canada to begin clinical trials in ... product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen).  KP201 ... moderate to moderately severe pain. The Health Canada ...
Breaking Medicine Technology:Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5Medimetriks Pharmaceuticals, Inc. Welcomes Independent Directors Andrew Lary and William Resnick to its Board of Directors 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 3
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... This convenient, procedural kit contains everything ... the methacholine challenge test quickly and efficiently: ... gas supply tubing, syringe and needle., ... available in the European Community., ,Intended ...
... Hand Held Nebulizer can be held at angles ... has a built in spill column, finger grooves ... medication setups and 7 feet of regular oxygen ... maintain small particle size and sustain optimum mist ...
Medicine Products: